(Q35319439)

7 August 2017

1 reference

title

Rhenium-186 hydroxyethylidene diphosphonate for the treatment of painful osseous metastases (English)

1 reference

7 August 2017

1 reference

Maxon HR 3rd

1

1 reference

7 August 2017

H. R. Maxon

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1375400

19 September 2022

S. R. Thomas

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1375400

19 September 2022

V. S. Hertzberg

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1375400

19 September 2022

L. E. Schroder

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1375400

19 September 2022

E. E. Englaro

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1375400

19 September 2022

R. Samaratunga

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1375400

19 September 2022

H. I. Scher

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1375400

19 September 2022

J. S. Moulton

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1375400

19 September 2022

E. A. Deutsch

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1375400

19 September 2022

K. F. Deutsch

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1375400

19 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1375400

19 September 2022

publication date

1 January 1992

1 reference

Seminars in Nuclear Medicine

7 August 2017

1 reference

7 August 2017

22

1 reference

7 August 2017

1

1 reference

7 August 2017

33-40

1 reference

The palliation of symptomatic osseous metastases: final results of the Study by the Radiation Therapy Oncology Group

7 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980155-2

Single-dose half-body irradiation for palliation of multiple bone metastases from solid tumors. Final Radiation Therapy Oncology Group report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980155-2

Preparation of rhenium-186 labelled EHDP and its possible use in the treatment of osseous neoplasms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980155-2

Preparation of 186Re-perrhenate for nuclear medical purposes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980155-2

Effect of pH on the formation of Tc(NaBH4)-MDP radiopharmaceutical analogues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980155-2

The effect of formulation conditions on the distribution of 99mTc(NaBH4)-HEDP components separated by anion exchange HPLC

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980155-2

In vivo distributions of some component fractions of Tc(NaBH4)-HEDP mixtures separated by anion exchange high performance liquid chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980155-2

The biological distributions of some technetium-MDP components isolated by anion exchange high performance liquid chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980155-2

HPLC separated fractions of 99mTc(NaBH4)-HEDP as myocardial infarct imaging agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980155-2

Re-186(Sn) HEDP for treatment of multiple metastatic foci in bone: human biodistribution and dosimetric studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980155-2

Re-186(Sn) HEDP for treatment of painful osseous metastases: initial clinical experience in 20 patients with hormone-resistant prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980155-2

Safety and efficacy of repeated sequential administrations of Re-186(Sn)HEDP as palliative therapy for painful skeletal metastases. Initial case reports of two patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980155-2

In vivo quantitation of lesion radioactivity using external counting methods

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980155-2

10.1016/S0001-2998(05)80155-2

7 January 2021

Identifiers

DOI

1 reference

7 August 2017

1 reference